United States · FDA National Drug Code directory
Fondaparinux Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67457-583_9448af58-144f-4611-a462-e8cb12cc7362
- Product NDC
- 67457-583
- Form
- INJECTION, SOLUTION
- Composition / generic term
- fondaparinux sodium
- Labeler
- Mylan Institutional LLC
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20150105
- Source listing expiry
- 20271231
Source-listed ingredients
- FONDAPARINUX SODIUM — 5 mg/.4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE, GLASS in 1 CARTON (67457-583-04) / .4 mL in 1 SYRINGE, GLASS (67457-583-00) · 67457-583-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →